In last trading session, Structure Therapeutics Inc ADR (NASDAQ:GPCR) saw 1.3 million shares changing hands with its beta currently measuring -1.87. Company’s recent per share
In the last trading session, 1.13 million shares of the Structure Therapeutics Inc ADR (NASDAQ:GPCR) were traded, and its beta was -1.79. Most recently the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting -1.78. At the close
In the last trading session, 1.39 million Structure Therapeutics Inc ADR (NASDAQ:GPCR) shares changed hands as the company’s beta touched -1.72. With the company’s per
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.72 and has seen 2.08 million shares traded in the last trading session. The company,
During the recent session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 1.35 million, with the beta value of the company hitting -1.37. At the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting -0.98. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 1.82 million during the last session, with the company’s beta value hitting -0.51. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.46 and has seen 2.06 million shares traded in the last trading session. The company,
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -1.46 and has seen 0.55 million shares traded in the recent trading session. The company,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
